Acadian Asset Management LLC Repligen Corp Transaction History

Acadian Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	BUY	$120.0 - $182.95 $150,120 - $228,870	1,251 New	1,251 $157,000
Q1 2022 May 12, 2022	SELL	$161.19 - $257.96 $149,423 - $239,128	-927 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$165.87 - $220.95 $62,367 - $83,077	-376 Reduced 28.86%	927 $185,000
Q1 2021 May 11, 2021	SELL	$180.37 - $226.26 $132,932 - $166,753	-737 Reduced 36.13%	1,303 $254,000
Q4 2020 Feb 11, 2021	BUY	$148.08 - $206.57 $302,083 - $421,402	2,040 New	2,040 $391,000
Q4 2019 Feb 06, 2020	SELL	$73.84 - $93.08 $6,940 - $8,749	-94 Closed	0 $0
Q3 2019 Nov 07, 2019	BUY	$76.65 - $95.51 $7,205 - $8,977	94 New	94 $7,000

488

54.2M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.02B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.